Free public records show Zhejiang Doer Biologics Co., Ltd. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Zhejiang Doer Biologics Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
6 active studies led by Zhejiang Doer Biologics Co., Ltd., of 9 in all
Source: ClinicalTrials.gov, Studies with Zhejiang Doer Biologics Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Zhejiang Doer Biologics Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Zhejiang Doer Biologics Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Zhejiang Doer Biologics Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Zhejiang Doer Biologics Co., Ltd. is in.
Stories on the topics Zhejiang Doer Biologics Co., Ltd. works in.
2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack…
Read
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
ReadSearch all reports for Zhejiang Doer Biologics Co., Ltd. All companies